Increasingly, and now almost ubiquitously, institutions are making direct cash investments (beyond patents) in select embryonic technologies to facilitate commercialization by adding value and decreasing risk pre-licensing. These programs go by various names, but, in essence, are generally referred to as Proof-of-Concept (PoC), Translational Research (TR) and/or Bridge the Gap (BtG) funds. Also increasingly, but far less pervasive than PoC/TR/BtG funds, institutions are creating funds and other vehicles to make seed investments in their start ups. Finally, some institutions have established and/or are exploring creating and managing true venture funds to finance the growth and generate economic returns from their start ups. This webinar, led by a world-class technology transfer expert, past AUTM president, and current venture capitalist, will discuss each of these innovation funds and their differing goals, success metrics, structures, management, decision-making, and sources of funds.